Celdara Medical, LLC

NIH SBIR/STTR award: Precision CAR-NK therapy for VK4-1 autoreactive B cells in autoimmune diseases: advancing treatment with preserved immune function.

USD 320,863.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of a Novel, Allogeneic Cell Therapy for Difficult to Treat IBD

USD 356,328.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of an immunotherapeutic agent for treatment of osteomyelitis

USD 320,863.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Engineered Tregs as a therapy to Gaucher syndrome

USD 310,564.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma

USD 1,024,401.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma

USD 1,228,902.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke

USD 421,106.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)

USD 921,394.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome

USD 955,865.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)